From Brain to Blood: Uncovering Potential Therapeutical Targets and Biomarkers for Huntington’s Disease Using an Integrative RNA-Seq Analytical Platform (BDASeq<sup>®</sup>)
Background: Huntington’s Disease (HD) remains without disease-modifying treatments, with existing therapies primarily targeting chorea symptoms and offering limited benefits. This study aims to identify druggable genes and potential biomarkers for HD, focusing on using RNA-Seq analysis to uncover mo...
Saved in:
Main Authors: | João Rafael Dias Pinto, Benedito Faustinoni Neto, Luciana Munhoz, Irina Kerkis, Rodrigo Pinheiro Araldi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/13/976 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Huntington’s disease modeling on HEK293 cell line
by: D. V. Sharipova, et al.
Published: (2017-12-01) -
Varenicline improves motor and cognitive symptoms in early Huntington&rsquo;s disease
by: McGregor A, et al.
Published: (2016-09-01) -
In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington’s Disease
by: Luis C. Morales, et al.
Published: (2025-05-01) -
Retinal and choroidal morphological changes in Huntington's disease
by: S. N. Svetozarskiy, et al.
Published: (2019-03-01) -
Gene Silencing Therapies for Huntington’s Disease
by: Chunlan Hao, et al.
Published: (2025-05-01)